EIS Eczacibasi Ilac, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (BIST: ECILC) Stock Analysis & Fundamentals

ECILCEIS Eczacibasi Ilac, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

BIST · TR · Healthcare · Drug Manufacturers - Specialty & Generic · eis.com.tr

76.35TRY+0.73%Mkt Cap: 1.24B $P/E: —Today

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.32BUSDP/E 16.5

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap1.24B $

Enterprise Value1.28B $

Revenue (TTM)222.99M $

Gross Profit78.74M $

Net Income (TTM)49.95M $

Revenue/Share0.3254 USD

Last Price76.35 TRY

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees904

CountryTR

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-250.79

EV/Revenue5.73

P/S5.57

P/B0.85

EPS (TTM)-3.38

EPS (Forward)—

52W Range

53.4529% of range132.60

52W High132.60 TRY

52W Low53.45 TRY

Profitability

Gross Margin33.36%

Oper. Margin-14.15%

EBITDA Margin-2.28%

Profit Margin21.16%

ROE3.42%

ROA2.78%

Growth

Revenue Growth-18.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF34.51M $

CapEx (TTM)7.90M $

FCF Margin-6.64%

FCF Yield-1.19%

Net Debt35.04M $

Net Debt/EBITDA-6.88

Balance Sheet

Debt/Equity0.05

Current Ratio1.47

Quick Ratio0.97

Book Value/Sh89.08 TRY

Cash/Share3.633 TRY

Dividends

Fwd Div Rate1.750 TRY

Trail. Div Rate1.490 TRY

Div. Yield2.30%

5Y Avg Yield2.04%

Payout Ratio57.42%

Ex-Div DateMay 6, 2026

Pay Date—

Splits

Last Split1.25:1

Split DateNov 4, 2016

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.685.26M

Float151.11M

Insiders77.95%

Institutions1.36%

Technical

SMA 5075.10 (+1.7%)

SMA 20093.23 (-18.1%)

Beta0.27

S&P 52W Chg18.16%

Avg Vol (30d)3.65M

Avg Vol (10d)5.12M

Technical Indicators

RSI (14)56.3

MACD0.2314

MACD Signal-0.8563

MACD Hist.+1.0878

BB Upper77.66 TRY

BB Middle71.22 TRY

BB Lower64.79 TRY

BB Width18.06%

ATR (14)2.824 TRY

Vol Ratio (20d)0.64x